566
Participants
Start Date
December 14, 2011
Primary Completion Date
August 28, 2017
Study Completion Date
July 19, 2018
Haloperidol
Haloperidol, up to 10mg q12 hours, will be administered intravenously (IV) by bolus over up to 5 minutes at concentrations of 5mg/mL. Patient will only receive IV while in the ICU.
Ziprasidone
Ziprasidone, up to 20mg q12 hours, will be administered intravenously (IV) by bolus over up to 5 minutes at concentrations of 10mg/mL. Patient will only receive IV while in the ICU.
Placebo
Placebo, up to 10mL q12 hours, will be administered intravenously (IV) by bolus over up to 5 minutes. Patient will only receive IV while in the ICU.
Albert Einstein Medical College-Montefiore Medical Center, The Bronx
University of Maryland Medical Center, Baltimore
Moses Cone Health System, Greensboro
University of Iowa, Iowa City
Baylor Health Care System, Dallas
Denver Health/University of Colorado Health Sciences Center, Denver
Yale University Medical Center, New Haven
Indiana University, Indianapolis
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
University of Michigan Health System, Ann Arbor
University of North Carolina - Chapel Hill, Chapel Hill
The Ohio State Medical Center, Columbus
University of Pennsylvania, Philadelphia
Vanderbilt University Medical Center, Nashville
University of Washington, Seattle
Vanderbilt University Medical Center
OTHER